FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition

Prices from
45.70

Sponsored links

COMPARE ALL WEBSHOPS (1)

Description

FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition

Description Description
Product Specifications Product specifications
Related results Related results
Next
Previous

Compare webshops (1)

Sponsored links · Some shops pay us a fee

Sort by:

€ 45.70

Description (0)

FDA Clinical Outcome Assessments and CDISC QRS supplements: Enabling Patient-Centric Drug Development Second Edition

Product specifications

Brand LAP LAMBERT Academic Publishing
EAN
  • 9786209608780

Springer

Enabling Person-Centric Healthcare Using Ambient Assistive Technology, Volume 2: Personalized and Patient-Centric...

€ 222.94
More Information More Info

Independently Published

R FOR CLINICAL TRIALS: FDA SUBMISSION WORKFLOWS, CDISC (SDTM/ADaM), DEFINE.XML AUTOMATION, AND...

€ 17.95
More Information More Info

LAP LAMBERT Academic Publishing

Application of DFE and DFMA for enabling sustainable development: Exclusively automotive sectors Second Edition

€ 74.67
More Information More Info

Independently Published

R FOR CLINICAL TRIALS: FDA SUBMISSION WORKFLOWS, CDISC (SDTM/ADaM), DEFINE.XML AUTOMATION, AND...

€ 25.85
More Information More Info
Featured Choice
€ 45.70
To Shop